XML 42 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity for the Current Year is as follows:

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2024

 

514,854

$

20.27

 

4.26

$

Granted

 

10,000

 

8.50

 

  

 

  

Exercised

 

 

 

  

 

  

Expired/Forfeited

 

(52,462)

 

29.35

 

  

 

  

Outstanding at December 31, 2024, and expected to vest

 

472,392

$

19.01

 

3.65

$

Exercisable at December 31, 2024

 

97,392

$

27.22

 

1.26

$

Schedule of Black-Scholes Assumptions for Fair Value of Options Granted

The fair values of the options granted were estimated at the respective dates of grant using the Black-Scholes option pricing model with the following range of assumptions:

Year Ended December 31, 

 

    

2024

    

2023

 

Expected Volatility

 

78

%  

89 – 90

%

Expected Dividend Yield

 

%  

%

Expected Life (Term, in years)

 

3.25

 

2.75 – 10

Risk-Free Interest Rate

 

4.46

%  

4.0 – 4.7

%

Schedule of options vesting upon achievement of target price

Of the total stock options outstanding at December 31, 2024, the vesting of 350,000 options is contingent upon the Company’s common stock achieving certain target prices as follows:

Target Prices

    

Number of Options Vesting

$30.00

100,000

$50.00

85,000

$70.00

70,000

$90.00

55,000

$110.00

40,000

Summary of Stock Option Activity for Non-Vested Options

The following table summarizes the Company’s stock option activity for non-vested options for the Current Year:

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2024

 

375,000

$

0.37

Granted

 

10,000

 

4.72

Vested

 

(10,000)

9.02

Forfeited or Canceled

 

 

Balance at December 31, 2024

 

375,000

$

0.24

Summary of Restricted Stock Activity

A summary of the Company’s restricted stock activity for the Current Year is as follows:

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2024

 

33,333

$

36.81

Granted

 

30,770

 

8.45

Vested

 

(28,770)

 

8.94

Expired/Forfeited

 

 

Outstanding at December 31, 2024

 

35,333

$

34.80

Summary of Warrant Activity

A summary of the Company’s warrant activity for the Current Year is as follows:

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2024

 

111,606

$

16.71

 

8.46

$

Issued

 

163,957

 

6.52

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

(11,606)

 

31.46

 

 

  

Outstanding at December 31, 2024

 

263,957

$

9.73

 

8.96

$

Exercisable at December 31, 2024

 

163,957

$

6.52

 

9.31

$

Schedule Of Common Stock Repurchased

The following table provides information with respect to restricted stock purchased and retired by the Company during the Current Year:

Number of

Shares

Purchased as

Part of

Total Number

Actual

Publicly

Fair value of

of Shares

Price Paid

Announced

Re-Purchased

Date

    

Purchased

    

per Share

    

Plan

    

Shares

July 31, 2024 (i)

1,344

$

7.20

 

$

9,680

August 31, 2024 (i)

2,760

7.03

19,411

September 30, 2024 (i)

2,594

7.48

19,411

October 31, 2024(i)

2,458

7.89

19,411

November 31, 2024 (i)

2,824

6.87

19,411

December 31, 2024 (i)

 

3,768

 

5.15

 

 

19,411

Total 2024

 

15,748

$

6.78

 

$

106,735

(i)The shares were exchanged from employees in connection with the income tax withholding obligations on behalf of such employees from the receipt of stock awards. The 2011 Plan and 2021 Plan allow for award holders to surrender vested shares to cover withholding tax liabilities.